Stem Cell-Derived Cardiomyocyte-Like Cells in Myocardial Regeneration

Author:

Cheng Pauline1,Rashad Ahmad2ORCID,Gangrade Ankit2ORCID,Barros Natan Roberto de2ORCID,Khademhosseini Ali2ORCID,Tam Jonathan1,Varadarajan Padmini3,Agrawal Devendra K.1ORCID,Thankam Finosh G.1ORCID

Affiliation:

1. Department of Translational Research, Western University of Health Sciences, Pomona, California, USA.

2. Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, California, USA.

3. University of California Riverside School of Medicine, Riverside, California, USA.

Publisher

Mary Ann Liebert Inc

Subject

Biomedical Engineering,Biochemistry,Biomaterials,Bioengineering

Reference111 articles.

1. 1. Institute of Medicine (US) Committee on Social Security Cardiovascular Disability Criteria. Ischemic Heart Disease. In: Cardiovascular Disability: Updating the Social Security Listings. National Academies Press (US): Washington, DC; 2010; pp. 101–132.

2. Pathophysiology of Myocardial Infarction

3. Predictors of late development of heart failure in stable survivors of myocardial infarction

4. Mechanical, inflammatory, and embolic complications of myocardial infarction: An emergency medicine review

5. Process engineering of human pluripotent stem cells for clinical application

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3